Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BIT/1TGTX stock hub

BIT/1TGTX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BIT/1TGTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.2B

Borsa Italiana

Market data

Live price

Current market quote for this ticker.

Current price

BIT/1TGTX

In the news

Latest news · BIT/1TGTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20

P25 n/aP50 n/aP75 n/a

Trailing P/E12.9

P25 n/aP50 n/aP75 n/a

ROE112.6

P25 n/aP50 n/aP75 n/a

ROIC18.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BIT/1TGTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

170

Groups with data

Currency

USD

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	IT
Employees	399
Employees Change	55%
Employees Change Percent	17.24
Enterprise value	EUR 5.4B
Exchange	Borsa Italiana
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 5.2B
Price	EUR 37.4
Price currency	EUR
Rev Per Employee	1,522,337.56x
Sic	2834
Symbol	bit/1TGTX
Website	https://www.tgtherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.76%
EV Earnings	13.39x
EV/EBIT	42.23x
EV/EBITDA	41.67x
EV/FCF	-435.81x
EV/Sales	9.01x
FCF yield	-0.24%
Forward P/E	20.02x
P/B ratio	10.2x
P/E ratio	12.88x
P/S ratio	8.5x
PE Ratio3 Y	80.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.35%
EBITDA Margin	21.36%
Gross margin	83.05%
Gross Profit	EUR 504.5M
Gross Profit Growth	72.19%
Gross Profit Growth Q	62.76%
Gross Profit Growth3 Y	322.97%
Gross Profit Growth5 Y	276.58%
Net Income	EUR 400.6M
Net Income Growth	1,079.81%
Net Income Growth Q	290.85%
Pretax Margin	17.46%
Profit Margin	65.95%
Profit Per Employee	EUR 1M
ROA	8.55
Roa5y	-14.08
ROCE	11.14
ROE	112.6
Roe5y	-23.37
ROIC	18.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	21.15%
EPS Growth	1,105.5
EPS Growth Q	300
Revenue Growth	81.26x
Revenue Growth Q	69.56x
Revenue Growth3 Y	333.92x
Revenue Growth5 Y	278.04x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.64
Assets	EUR 1.3B
Cash	EUR 446.2M
Current Assets	EUR 921.7M
Current Liabilities	EUR 158.7M
Debt	EUR 653.6M
Debt EBITDA	EUR 4.97
Debt Equity	EUR 1.29
Debt FCF	EUR -53.1
Equity	EUR 505.7M
Interest Coverage	5.41
Liabilities	EUR 820.2M
Long Term Assets	EUR 404.3M
Long Term Liabilities	EUR 661.6M
Net Cash	EUR -207.4M
Net Cash By Market Cap	EUR -4.02
Net Debt EBITDA	EUR 1.6
Net Debt Equity	EUR 0.41
Tangible Book Value	EUR 505.7M
Tangible Book Value Per Share	EUR 3.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.81
Inventory Turnover	0.83
Net Working Capital	EUR 335.9M
Quick ratio	4.84
Working Capital	EUR 780.4M
Working Capital Turnover	EUR 0.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	21.13%
200-day SMA	27.38
50-day SMA	28.2
50-day SMA vs 200-day SMA	50over200
All Time High	40
All Time High Change	-6.49%
All Time High Date	2025-05-02
All Time Low	21.8
All Time Low Change	71.56%
All Time Low Date	2026-02-06
ATR	1.09
Ch YTD	45.92
High52	37.4
High52 Date	2026-05-08
High52ch	0%
Low52	21.8
Low52 Date	2026-02-06
Low52ch	71.56%
Ma50ch	32.64%
Price vs 200-day SMA	36.61%
RSI	76.44
RSI Monthly	0
RSI Weekly	68.89
Sharpe ratio	0.57x
Sortino ratio	0.93
Total Return	2.27%
Tr YTD	45.92
Tr1m	29.86%
Tr1w	23.84%
Tr3m	55.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 129.7M
Operating Income Growth	149.9
Operating Income Growth Q	303.6
Operating margin	21.35

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	135,104,730%
Net Borrowing	417,753,567.1
Shares Insiders	4.71%
Shares Institutions	78.09%
Shares Qo Q	0.44%
Shares Yo Y	-2.27%
Short Ratio	14.07

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -72.7M
Average Volume	65.85x
Bv Per Share	3.57
CAPEX	EUR -208,152
Ch1m	29.86
Ch1w	23.84
Ch1y	21.13
Ch3m	55.9
Ch6m	34.32
Change	2.19%
Close	36.6
Depreciation Amortization	70,380.8
Earnings Date	2026-05-06
EBIT	EUR 129.7M
EBITDA	EUR 129.7M
EPS	EUR 2.49
F Score	3
FCF	EUR -12.3M
FCF EV Yield	-0.23x
Financing CF	266,436,295
Fiscal Year End	December
Founded	1,993
Graham Number	15.14223
Graham Upside	-58.63
Income Tax	EUR -294.5M
Investing CF	14,630,484
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Ma150	27.46
Ma150ch	36.2%
Ma20	30.97
Ma20ch	20.76%
Net CF	268,967,076
Ppne	5,495,641.7
Price Date	2026-05-08
Price EBITDA	EUR 39.78
Ptbv Ratio	10.2
Relative Volume	0.02x
Revenue	607,412,688x
SBC By Revenue	9.94x
Share Based Comp	60,405,710
Tax By Revenue	-48.49x
Tr6m	34.32%
Z Score	3.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BIT/1TGTX pay a dividend?

Capital-return profile for this ticker.

Performance

BIT/1TGTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BIT/1TGTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+78.1%

Share of float held by funds and institutions

Insider ownership

+4.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BIT/1TGTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

76.4

Above 70: short-term overbought

Price vs 200-day MA

+36.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.57

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BIT/1TGTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/1TGTX stock rating?

bit/1TGTX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/1TGTX analysis?

The full report lives at /stocks/bit/1TGTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/1TGTX?

The latest report frames bit/1TGTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/1TGTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.